Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia
- PMID: 32565908
- PMCID: PMC7284961
- DOI: 10.1155/2020/2509875
Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia
Abstract
Introduction: Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes. Several studies conducted in different hospitals revealed a high incidence of inappropriate prescription of beta-blockers among hospitalized patients. Therefore, it is important to identify inappropriate beta-blocker prescribing since they may increase the risk of hospitalizations. Despite this, there was no study conducted related to drug use evaluation of beta-blockers in Nedjo general hospital (NGH). Thus, this study was aimed at assessing the use evaluation of beta-blockers in medical wards of NGH.
Methods: A retrospective cross-sectional study was conducted at medical wards of NGH from January 1, 2016, to December 31, 2017.
Results: Out of the total of 149 medical record of patients that contains beta-blockers, 84 (56.37%) were males and about one-third (31.54%) of the patients ages were between 41 and 50 years. Propranolol was the most commonly prescribed beta-blocker (62.76%), and 94.56% of beta-blockers were prescribed with correct indication. There were about 51%, 46.31%, 64.43%, and 46.98% of beta-blockers prescribed with the correct dose, duration, frequency, and route of administration, respectively. Regarding the routes of administration, 70 (46.98%) of them were prescribed with the correct route. Most drugs interacting were propranolol with cimetidine 26 (68.42%), and the most frequent condition for which beta-blockers were prescribed was hypertension (32.89%).
Conclusion: Overall, there was an inappropriate use of beta-blockers in terms of dosage and durations. So, prescribers of NGH should strictly adhere to the national treatment guideline when prescribing medications. Additionally, drug information centers have proved useful and effective in promoting rational drug use. Hence, it should be recommended for general use.
Copyright © 2020 Ginenus Fekadu et al.
Conflict of interest statement
The authors declare that no conflicts of interest exist.
Similar articles
-
Evaluation of drug-prescribing patterns based on the WHO prescribing indicators at outpatient clinics of five hospitals in Jordan: a cross-sectional study .Int J Clin Pharmacol Ther. 2017 May;55(5):425-432. doi: 10.5414/CP202733. Int J Clin Pharmacol Ther. 2017. PMID: 28139971
-
Evaluation of trends of drug-prescribing patterns based on WHO prescribing indicators at outpatient departments of four hospitals in southern Ethiopia.Drug Des Devel Ther. 2015 Aug 10;9:4551-7. doi: 10.2147/DDDT.S83588. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26309400 Free PMC article.
-
General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.Clin Res Cardiol. 2016 May;105(5):441-50. doi: 10.1007/s00392-015-0939-8. Epub 2015 Nov 9. Clin Res Cardiol. 2016. PMID: 26552905
-
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.Heart. 2016 Dec 1;102(23):1909-1914. doi: 10.1136/heartjnl-2016-309458. Epub 2016 Jul 5. Heart. 2016. PMID: 27380949 Free PMC article.
-
Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.Genes (Basel). 2024 Mar 20;15(3):379. doi: 10.3390/genes15030379. Genes (Basel). 2024. PMID: 38540438 Free PMC article. Review.
References
-
- World Health Organization. WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy 2000-2003. Geneva: World Health Organization; 2000.
-
- Wong M. C. S., Wang H. H. X., Jiang J. Y., Leeder S., Griffiths S. M. Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong. Asia Pacific family medicine. 2011;10(1):p. 10. doi: 10.1186/1447-056X-10-10. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources